HEADER HYDROLASE 06-MAR-23 8CQI TITLE HUMAN HEPARANASE IN COMPLEX WITH INHIBITOR R3794 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: DPG 155-157 EXPRESSION TAG; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEPARANASE; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: ENDO-GLUCORONIDASE,HEPARANASE-1,HPA1; COMPND 10 EC: 3.2.1.166; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS HYDROLASE, GLYCOSIDE HYDROLASE, PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.M.MORAN,G.J.DAVIES,C.CHEN,E.V.NIEUWENDIJK,L.WU,F.SKOULIKOPOULOU, AUTHOR 2 V.V.RIET,H.S.OVERKLEEFT,Z.ARMSTRONG REVDAT 2 24-JAN-24 8CQI 1 JRNL REVDAT 1 10-JAN-24 8CQI 0 JRNL AUTH Y.CHEN,A.M.C.H.VAN DEN NIEUWENDIJK,L.WU,E.MORAN, JRNL AUTH 2 F.SKOULIKOPOULOU,V.VAN RIET,H.S.OVERKLEEFT,G.J.DAVIES, JRNL AUTH 3 Z.ARMSTRONG JRNL TITL MOLECULAR BASIS FOR INHIBITION OF HEPARANASES AND JRNL TITL 2 BETA-GLUCURONIDASES BY SIASTATIN B. JRNL REF J.AM.CHEM.SOC. V. 146 125 2024 JRNL REFN ESSN 1520-5126 JRNL PMID 38118176 JRNL DOI 10.1021/JACS.3C04162 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0405 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 28924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1499 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2109 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.3310 REMARK 3 BIN FREE R VALUE SET COUNT : 119 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3546 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 103 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.80000 REMARK 3 B22 (A**2) : -3.01000 REMARK 3 B33 (A**2) : -1.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.225 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.212 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.071 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3784 ; 0.007 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 3534 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5143 ; 1.484 ; 1.650 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8141 ; 0.470 ; 1.567 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 464 ; 6.947 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 18 ; 4.581 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 574 ;16.106 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 585 ; 0.062 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4344 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 864 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1849 ; 3.782 ; 4.422 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1849 ; 3.771 ; 4.423 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2315 ; 5.278 ; 7.938 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2316 ; 5.277 ; 7.940 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1935 ; 3.637 ; 4.640 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1935 ; 3.637 ; 4.639 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2827 ; 5.286 ; 8.460 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4075 ; 6.835 ;41.660 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4059 ; 6.814 ;41.340 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8CQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1292128230. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 46.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 5.5, 0.1M MAGNESIUM REMARK 280 CHLORIDE, 18% PEG 3,350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.75950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 155 REMARK 465 PRO A 156 REMARK 465 GLY A 157 REMARK 465 LYS A 158 REMARK 465 LYS A 427 REMARK 465 ARG A 428 REMARK 465 ASP B -2 REMARK 465 PRO B -1 REMARK 465 GLY B 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 159 CD CE NZ REMARK 470 LYS A 161 CG CD CE NZ REMARK 470 LEU A 197 CG CD1 CD2 REMARK 470 LEU A 207 CD1 REMARK 470 LYS A 214 NZ REMARK 470 LYS A 231 CD CE NZ REMARK 470 ILE A 235 CD1 REMARK 470 ILE A 237 CD1 REMARK 470 LEU A 252 CD1 REMARK 470 ARG A 254 NH2 REMARK 470 THR A 257 CG2 REMARK 470 LYS A 259 CD CE NZ REMARK 470 ASN A 260 ND2 REMARK 470 ARG A 273 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 277 NZ REMARK 470 LYS A 284 CG CD CE NZ REMARK 470 GLN A 328 CD OE1 NE2 REMARK 470 GLU A 396 CG CD OE1 OE2 REMARK 470 SER A 426 CB OG REMARK 470 ARG A 429 NH1 REMARK 470 THR A 440 CG2 REMARK 470 GLU A 447 CG CD OE1 OE2 REMARK 470 LEU A 498 CD1 REMARK 470 LYS A 501 CD CE NZ REMARK 470 GLN A 506 NE2 REMARK 470 ARG A 517 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 538 CE NZ REMARK 470 ILE A 543 CG2 REMARK 470 GLN B 1 N REMARK 470 LYS B 72 CE NZ REMARK 470 GLU B 74 CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 459 O5 NAG A 609 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 194 -168.79 -110.64 REMARK 500 THR A 333 -29.58 -148.67 REMARK 500 GLU A 343 116.22 -176.67 REMARK 500 SER A 345 -165.87 -176.93 REMARK 500 LEU A 419 -158.43 -113.66 REMARK 500 PRO A 469 33.08 -91.29 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CQI A 158 543 UNP Q9Y251 HPSE_HUMAN 158 543 DBREF 8CQI B 1 74 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 8CQI ASP A 155 UNP Q9Y251 EXPRESSION TAG SEQADV 8CQI PRO A 156 UNP Q9Y251 EXPRESSION TAG SEQADV 8CQI GLY A 157 UNP Q9Y251 EXPRESSION TAG SEQADV 8CQI ARG A 307 UNP Q9Y251 LYS 307 VARIANT SEQADV 8CQI ASP B -2 UNP Q9Y251 EXPRESSION TAG SEQADV 8CQI PRO B -1 UNP Q9Y251 EXPRESSION TAG SEQADV 8CQI GLY B 0 UNP Q9Y251 EXPRESSION TAG SEQRES 1 A 389 ASP PRO GLY LYS LYS PHE LYS ASN SER THR TYR SER ARG SEQRES 2 A 389 SER SER VAL ASP VAL LEU TYR THR PHE ALA ASN CYS SER SEQRES 3 A 389 GLY LEU ASP LEU ILE PHE GLY LEU ASN ALA LEU LEU ARG SEQRES 4 A 389 THR ALA ASP LEU GLN TRP ASN SER SER ASN ALA GLN LEU SEQRES 5 A 389 LEU LEU ASP TYR CYS SER SER LYS GLY TYR ASN ILE SER SEQRES 6 A 389 TRP GLU LEU GLY ASN GLU PRO ASN SER PHE LEU LYS LYS SEQRES 7 A 389 ALA ASP ILE PHE ILE ASN GLY SER GLN LEU GLY GLU ASP SEQRES 8 A 389 PHE ILE GLN LEU HIS LYS LEU LEU ARG LYS SER THR PHE SEQRES 9 A 389 LYS ASN ALA LYS LEU TYR GLY PRO ASP VAL GLY GLN PRO SEQRES 10 A 389 ARG ARG LYS THR ALA LYS MET LEU LYS SER PHE LEU LYS SEQRES 11 A 389 ALA GLY GLY GLU VAL ILE ASP SER VAL THR TRP HIS HIS SEQRES 12 A 389 TYR TYR LEU ASN GLY ARG THR ALA THR ARG GLU ASP PHE SEQRES 13 A 389 LEU ASN PRO ASP VAL LEU ASP ILE PHE ILE SER SER VAL SEQRES 14 A 389 GLN LYS VAL PHE GLN VAL VAL GLU SER THR ARG PRO GLY SEQRES 15 A 389 LYS LYS VAL TRP LEU GLY GLU THR SER SER ALA TYR GLY SEQRES 16 A 389 GLY GLY ALA PRO LEU LEU SER ASP THR PHE ALA ALA GLY SEQRES 17 A 389 PHE MET TRP LEU ASP LYS LEU GLY LEU SER ALA ARG MET SEQRES 18 A 389 GLY ILE GLU VAL VAL MET ARG GLN VAL PHE PHE GLY ALA SEQRES 19 A 389 GLY ASN TYR HIS LEU VAL ASP GLU ASN PHE ASP PRO LEU SEQRES 20 A 389 PRO ASP TYR TRP LEU SER LEU LEU PHE LYS LYS LEU VAL SEQRES 21 A 389 GLY THR LYS VAL LEU MET ALA SER VAL GLN GLY SER LYS SEQRES 22 A 389 ARG ARG LYS LEU ARG VAL TYR LEU HIS CYS THR ASN THR SEQRES 23 A 389 ASP ASN PRO ARG TYR LYS GLU GLY ASP LEU THR LEU TYR SEQRES 24 A 389 ALA ILE ASN LEU HIS ASN VAL THR LYS TYR LEU ARG LEU SEQRES 25 A 389 PRO TYR PRO PHE SER ASN LYS GLN VAL ASP LYS TYR LEU SEQRES 26 A 389 LEU ARG PRO LEU GLY PRO HIS GLY LEU LEU SER LYS SER SEQRES 27 A 389 VAL GLN LEU ASN GLY LEU THR LEU LYS MET VAL ASP ASP SEQRES 28 A 389 GLN THR LEU PRO PRO LEU MET GLU LYS PRO LEU ARG PRO SEQRES 29 A 389 GLY SER SER LEU GLY LEU PRO ALA PHE SER TYR SER PHE SEQRES 30 A 389 PHE VAL ILE ARG ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 77 ASP PRO GLY GLN ASP VAL VAL ASP LEU ASP PHE PHE THR SEQRES 2 B 77 GLN GLU PRO LEU HIS LEU VAL SER PRO SER PHE LEU SER SEQRES 3 B 77 VAL THR ILE ASP ALA ASN LEU ALA THR ASP PRO ARG PHE SEQRES 4 B 77 LEU ILE LEU LEU GLY SER PRO LYS LEU ARG THR LEU ALA SEQRES 5 B 77 ARG GLY LEU SER PRO ALA TYR LEU ARG PHE GLY GLY THR SEQRES 6 B 77 LYS THR ASP PHE LEU ILE PHE ASP PRO LYS LYS GLU HET NAG A 601 14 HET NAG A 602 14 HET NAG A 603 14 HET NAG A 604 14 HET VGO A 605 12 HET EDO A 606 4 HET LYY A 607 9 HET EDO A 608 4 HET NAG A 609 15 HET CL A 610 1 HET CL A 611 1 HET CL A 612 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM VGO (3~{S},4~{S})-4,5,5-TRIS(OXIDANYL)PIPERIDINE-3- HETNAM 2 VGO CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM LYY 1,5-ANHYDRO-D-ARABINITOL HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 5(C8 H15 N O6) FORMUL 7 VGO C6 H11 N O5 FORMUL 8 EDO 2(C2 H6 O2) FORMUL 9 LYY C5 H10 O4 FORMUL 12 CL 3(CL 1-) FORMUL 15 HOH *135(H2 O) HELIX 1 AA1 SER A 166 SER A 180 1 15 HELIX 2 AA2 SER A 201 GLY A 215 1 15 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 ARG A 272 GLY A 287 1 16 HELIX 7 AA7 GLU A 288 ILE A 290 5 3 HELIX 8 AA8 GLU A 308 LEU A 311 5 4 HELIX 9 AA9 ASN A 312 SER A 332 1 21 HELIX 10 AB1 THR A 358 ALA A 360 5 3 HELIX 11 AB2 ALA A 361 GLY A 376 1 16 HELIX 12 AB3 LEU A 401 LEU A 413 1 13 HELIX 13 AB4 HIS A 486 SER A 490 5 5 HELIX 14 AB5 VAL A 539 ILE A 543 5 5 HELIX 15 AB6 ASN B 29 ASP B 33 5 5 HELIX 16 AB7 ARG B 35 SER B 42 1 8 HELIX 17 AB8 SER B 42 LEU B 52 1 11 HELIX 18 AB9 GLY B 61 ASP B 65 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 67 PHE B 69 1 O ILE B 68 N SER A 163 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 ILE A 218 LEU A 222 1 O GLU A 221 N LEU A 188 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 SER A 292 ASN A 301 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 LYS A 338 TYR A 348 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 VAL A 380 ARG A 382 1 O MET A 381 N LEU A 341 SHEET 7 AA2 9 LEU B 22 ASP B 27 1 O SER B 23 N VAL A 380 SHEET 8 AA2 9 ALA B 55 GLY B 60 1 O ARG B 58 N ILE B 26 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ILE A 185 O PHE B 59 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 GLN A 474 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 PRO A 515 -1 O LYS A 514 N LYS A 477 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 GLN A 474 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ARG A 535 -1 O ARG A 535 N GLN A 474 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N TYR A 434 O TYR A 453 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N LYS A 417 O CYS A 437 SHEET 8 AA4 8 HIS B 15 LEU B 16 -1 O HIS B 15 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 3 PHE B 9 -1 O ASP B 7 N SER A 422 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N TYR A 463 O VAL B 4 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 524 N LYS A 462 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.05 LINK ND2 ASN A 162 C1 NAG A 604 1555 1555 1.46 LINK ND2 ASN A 200 C1 NAG A 601 1555 1555 1.49 LINK ND2 ASN A 217 C1 NAG A 602 1555 1555 1.47 LINK ND2 ASN A 238 C1 NAG A 603 1555 1555 1.46 CISPEP 1 GLY A 265 PRO A 266 0 1.03 CISPEP 2 GLN A 383 VAL A 384 0 -0.99 CISPEP 3 TYR A 468 PRO A 469 0 -1.11 CISPEP 4 GLY A 484 PRO A 485 0 9.73 CISPEP 5 SER B 53 PRO B 54 0 0.02 CRYST1 46.769 71.519 79.320 90.00 95.27 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021382 0.000000 0.001971 0.00000 SCALE2 0.000000 0.013982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012661 0.00000